Clinical Trial Update: Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II trial of BAX2398/5-FU/Calcium Levofolinate in metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• BAX2398
• Calcium Levofolinate (calcium levofolinate)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED